Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 12.90 is 90% above its 5-year average of 6.80, near the low end of its 5-year range (0.12–121.03).
As of the fiscal period ended Tuesday, June 30, 2026. 16.73% above its 12-month average of 11.05.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.90.
QUICK RATIO (ACID-TEST)
12.90
QUICK RATIO (ACID-TEST) AVG TTM
11.05
QUICK RATIO (ACID-TEST) AVG 3Y
8.26
QUICK RATIO (ACID-TEST) AVG 5Y
6.80
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.73%
CURRENT VS 3Y AVG
+56.17%
CURRENT VS 5Y AVG
+89.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+284.50%
vs the sector median at left
Zura Bio Limited
Market Cap
$376.19M
Quick Ratio (Acid-Test)
12.90
TTM Avg
11.05
3Y Avg
8.26
5Y Avg
6.80
Market Cap
$376.01M
Quick Ratio (Acid-Test)
2.39
TTM Avg
2.24
3Y Avg
1.74
5Y Avg
3.80
Market Cap
$374.50M
Quick Ratio (Acid-Test)
9.06
TTM Avg
8.18
3Y Avg
5.96
5Y Avg
5.74
Market Cap
$380.37M
Quick Ratio (Acid-Test)
1.67
TTM Avg
1.85
3Y Avg
1.69
5Y Avg
1.72
Market Cap
$369.50M
Quick Ratio (Acid-Test)
5.88
TTM Avg
5.65
3Y Avg
4.80
5Y Avg
5.41
Market Cap
$385.15M
Quick Ratio (Acid-Test)
2.86
TTM Avg
2.54
3Y Avg
2.71
5Y Avg
3.53
Market Cap
$361.64M
Quick Ratio (Acid-Test)
12.19
TTM Avg
4.83
3Y Avg
10.20
5Y Avg
8.85
Market Cap
$359.53M
Quick Ratio (Acid-Test)
5.66
TTM Avg
6.21
3Y Avg
5.34
5Y Avg
8.05
Market Cap
$396.93M
Quick Ratio (Acid-Test)
8.92
TTM Avg
6.16
3Y Avg
7.06
5Y Avg
7.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zura Bio Limited (ZURA) | $376.19M | 12.90 | 11.05 | 8.26 | 6.80 |
| Canopy Growth Corporation (CGC)vs › | $376.01M | 2.39 | 2.24 | 1.74 | 3.80 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | 9.06 | 8.18 | 5.96 | 5.74 |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | 1.67 | 1.85 | 1.69 | 1.72 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | 5.88 | 5.65 | 4.80 | 5.41 |
| REGENXBIO Inc. (RGNX)vs › | $385.15M | 2.86 | 2.54 | 2.71 | 3.53 |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | 12.19 | 4.83 | 10.20 | 8.85 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | 5.66 | 6.21 | 5.34 | 8.05 |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | 8.92 | 6.16 | 7.06 | 7.06 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | 24.16 | 12.00 | 8.65 | 7.93 |
Quick Ratio
12.90
Excludes inventory
Current Ratio
12.90
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 12.90 |
| 2026-03-31 | 19.33 |
| 2025-12-31 | 9.05 |
| 2025-09-30 | 5.58 |
| 2025-06-30 | 8.40 |
| 2025-03-31 | 8.14 |
| 2024-12-31 | 9.16 |
| 2024-09-30 | 10.36 |
| 2024-06-30 | 12.57 |
| 2024-03-31 | 6.17 |
| 2023-12-31 | 4.97 |
| 2023-09-30 | 6.15 |
| 2023-06-30 | 5.68 |
| 2023-03-31 | 8.89 |
| 2022-12-31 | 0.12 |
| 2022-09-30 | 1.48 |
| 2022-06-30 | 3.68 |
| 2022-03-31 | 121.03 |
| 2021-12-31 | 4.23 |
| 2021-09-30 | 11.47 |
| 2021-06-30 | 0.13 |
| 2021-03-30 | 0.00 |
